{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:26:28Z","timestamp":1774351588522,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1832,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/ki.2010.268","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T12:42:37Z","timestamp":1281530557000},"page":"1068-1074","source":"Crossref","is-referenced-by-count":42,"title":["Sirolimus for calcineurin inhibitors in organ transplantation: contra"],"prefix":"10.1016","volume":"78","author":[{"given":"Paolo","family":"Cravedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.268_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0015","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.268_bb0020","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 8","key":"10.1038\/ki.2010.268_bb0025","first-page":"viii61","article-title":"Sirolimus in renal transplantation","volume":"22","author":"Morath","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.268_bb0030","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.tp.0000178393.78084.9b","article-title":"Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function","volume":"80","author":"Russ","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2215\/CJN.00340107","article-title":"Sirolimus: defining nephrotoxicity in the renal transplant recipient","volume":"2","author":"Tomlanovich","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1038\/ki.2010.268_bb0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994\u20132004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1440-1797.2007.00859.x","article-title":"Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991\u20132005","volume":"13","author":"Chang","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2010.268_bb0055","unstructured":"2008 OPTN\/SRTR Annual Report, available at http:\/\/www.ustransplant.org Accessed on 27 July, 2010."},{"key":"10.1038\/ki.2010.268_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.268_bb0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0075","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/01.tp.0000241077.83511.be","article-title":"Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants","volume":"82","author":"Jones","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0b013e318184112c","article-title":"Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma","volume":"86","author":"Barozzi","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"10.1038\/ki.2010.268_bb0090","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/TP.0b013e3181b9d0da","article-title":"Prospective observational study of sirolimus as primary immunosuppression after renal transplantation","volume":"88","author":"Pescovitz","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/460041a","article-title":"Immunology: a metabolic switch to memory","volume":"460","author":"Prlic","year":"2009","journal-title":"Nature"},{"key":"10.1038\/ki.2010.268_bb0100","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.tp.0000179106.07382.6a","article-title":"Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state","volume":"80","author":"Thaunat","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0105","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1600-6143.2009.02832.x","article-title":"The multifunctional role of mTOR in innate immunity: implications for transplant immunity","volume":"9","author":"Saemann","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrneph.2009.168","article-title":"Transplantation: time to rethink immunosuppression by mTOR inhibitors?","volume":"5","author":"Saemann","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2010.268_bb0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/ki.2010.268_bb0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.tp.0000284808.28353.2c","article-title":"Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury","volume":"84","author":"Ruggenenti","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00007890-200104270-00014","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group","volume":"71","author":"Mycophenolate Mofetil Acute Renal Rejection Study Group","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0135","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/j.1600-6143.2009.02803.x","article-title":"Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus","volume":"9","author":"Servais","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0140","first-page":"76","article-title":"Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat","volume":"1","author":"Perico","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0145","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0150","doi-asserted-by":"crossref","first-page":"F418","DOI":"10.1152\/ajprenal.90319.2008","article-title":"mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes","volume":"296","author":"Vollenbroker","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.268_bb0155","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/ndt\/gfp367","article-title":"Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?","volume":"24","author":"Torras","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.268_bb0160","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/j.1523-1755.2005.00732.x","article-title":"Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy","volume":"68","author":"Coombes","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.268_bb0165","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/01.tp.0000185200.17589.74","article-title":"Proteinuria following a switch from calcineurin inhibitors to sirolimus","volume":"80","author":"Letavernier","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0175","doi-asserted-by":"crossref","first-page":"F693","DOI":"10.1152\/ajprenal.2001.281.4.F693","article-title":"Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells","volume":"281","author":"Lieberthal","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.268_bb0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-6143.2003.00078.x","article-title":"Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation","volume":"3","author":"McTaggart","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0185","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1681\/ASN.2004030180","article-title":"Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy","volume":"16","author":"Bonegio","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0190","first-page":"561A","article-title":"Sirolimus therapy in idiopathic and lupus membranous nephropathy [abstract]","volume":"19","author":"Austin","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0195","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200110150-00011","article-title":"Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients","volume":"72","author":"Hoogeveen","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0200","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1600-6143.2008.02272.x","article-title":"Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients","volume":"8","author":"Kasiske","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0205","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1034\/j.1600-6143.2002.20610.x","article-title":"Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model","volume":"2","author":"Blum","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0210","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0215","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1681\/ASN.2006030196","article-title":"Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?","volume":"17","author":"Di Paolo","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.268_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1038\/ki.2010.268_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1007159422667","article-title":"Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells","volume":"211","author":"Syed","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1038\/ki.2010.268_bb0230","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI32959","article-title":"Recovery from diabetes in mice by beta cell regeneration","volume":"117","author":"Nir","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.268_bb0235","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.transproceed.2008.10.019","article-title":"Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine","volume":"40","author":"Kahan","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.268_bb0240","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.tp.0000235545.49391.1b","article-title":"Sirolimus interferes with iron homeostasis in renal transplant recipients","volume":"82","author":"Maiorano","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.TP.0000128628.31556.B1","article-title":"A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications","volume":"78","author":"Montalbano","year":"2004","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0250","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0b013e3181a05b7a","article-title":"Management of side effects of sirolimus therapy","volume":"87","author":"Stallone","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1600-6143.2006.01678.x","article-title":"Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus","volume":"7","author":"Chuang","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0260","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/01.TP.0000093502.26208.42","article-title":"The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients","volume":"76","author":"Flechner","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0265","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/TP.0b013e318192dd56","article-title":"A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients","volume":"87","author":"Tiong","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0270","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1600-6143.2008.02267.x","article-title":"Sirolimus may reduce fertility in male renal transplant recipients","volume":"8","author":"Zuber","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.268_bb0275","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1432-2277.2009.00839.x","article-title":"High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation","volume":"22","author":"Alfadhli","year":"2009","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2010.268_bb0280","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/01.TP.0000147301.41864.C0","article-title":"Alterations of the female reproductive system in recipients of islet grafts","volume":"78","author":"Cure","year":"2004","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0285","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1399-0012.2005.00356.x","article-title":"Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients","volume":"19","author":"Garrean","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1038\/ki.2010.268_bb0290","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","article-title":"Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients","volume":"72","author":"Morelon","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4065\/79.4.541","article-title":"Sirolimus-associated diffuse alveolar hemorrhage","volume":"79","author":"Vlahakis","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/ki.2010.268_bb0300","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(09)60709-1","article-title":"Sirolimus to replace calcineurin inhibitors? Too early yet","volume":"373","author":"Cravedi","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.268_bb0305","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-09-2340","article-title":"Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2","volume":"70","author":"Yu","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/ki.2010.268_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","article-title":"Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy","volume":"2","author":"Yuan","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1038\/ki.2010.268_bb0315","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1586\/erv.09.115","article-title":"Rapamycin: could it enhance vaccine efficacy?","volume":"8","author":"Nam","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1038\/ki.2010.268_bb0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.tp.0000268524.27506.39","article-title":"BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes","volume":"84","author":"Benavides","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0325","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","article-title":"Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs","volume":"88","author":"Egli","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0330","doi-asserted-by":"crossref","first-page":"20476","DOI":"10.1073\/pnas.0810843106","article-title":"Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1","volume":"105","author":"Heredia","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2010.268_bb0335","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/TP.0b013e318160d3c9","article-title":"Prospective comparison of the use of sirolimus and cyclosporine in recipients of kidney from an expanded criteria donor","volume":"85","author":"Durrbach","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0340","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2007.02934.x","article-title":"Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients","volume":"64","author":"Pescovitz","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1038\/ki.2010.268_bb0345","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.tp.0000258586.52777.4c","article-title":"Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs","volume":"83","author":"Flechner","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.268_bb0350","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T09:18:12Z","timestamp":1711703892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815544360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0085253815544360"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.268","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}